An Auditable Pricing Reference Framework for Medical Data Products: An Early Proof-of-Concept Study
Symmetry · 24.07.2026 · 18 (8) · 1263
DOI: 10.3390/sym18081263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Symmetry, online erschienen am 24.07.2026. Verfasst von Junwei Wang und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Key R&D Program of China Young Scientist Project.
Abstract (Originalsprache)
Exchange-listed medical data products create information and pricing asymmetry because sellers, buyers, and governance reviewers do not observe the same product boundaries, scenario permissions, processing depth, or compliance costs. This study proposes SM-DPF, an auditable pricing reference framework that makes these asymmetric conditions explicit through a reproducible three-layer chain: a public investment anchor, a locked structural scoring model, and a proposed future market learning governance interface that is not implemented or evaluated in the present study. Using 23 de-identified transaction-descriptive records from a single exchange context across insurance claims, model pretraining, and pharmaceutical R&D, the pricing reference outputs y0,i show in-sample diagnostic consistency with de-identified transaction prices yi, with an overall mean absolute percentage error of 4.82% and median absolute percentage error of 4.55%. The same 23 records informed the initial scenario-response calibration and the subsequent diagnostics; the reported errors and correlations are, therefore, in-sample diagnostics only. SM-DPF is a governance-oriented reference tool for transparent listing decisions and audit replay with no transaction price prediction claim.
Förderung
- National Key Research and Development Program of China
- National Key R&D Program of China Young Scientist Project
Zitieren
APA
Wang, J., Dai, W., Zhu, K., & Qu, B. (2026). An Auditable Pricing Reference Framework for Medical Data Products: An Early Proof-of-Concept Study. Symmetry, 18(8), 1263. https://doi.org/10.3390/sym18081263
Vancouver
Wang J, Dai W, Zhu K, Qu B. An Auditable Pricing Reference Framework for Medical Data Products: An Early Proof-of-Concept Study. Symmetry. 2026;18(8):1263. doi:10.3390/sym18081263
BibTeX
@article{Wang2026,
author = {Wang, Junwei and Dai, Wei and Zhu, Konglin and Qu, Bo},
title = {An Auditable Pricing Reference Framework for Medical Data Products: An Early Proof-of-Concept Study},
journal = {Symmetry},
year = {2026},
volume = {18},
number = {8},
pages = {1263},
doi = {10.3390/sym18081263}
}
EUVIMED